Lab-Made stem cells tested as rescue for dangerous transplant complication
NCT ID NCT06321198
Summary
This early-stage study is testing a new treatment for a severe complication called graft-versus-host disease (GVHD) that can happen after a bone marrow or stem cell transplant. The treatment uses special cells (iMSCs) grown in a lab from stem cells. Researchers want to see if these cells are safe and might help control the disease in patients whose GVHD hasn't improved with standard steroid treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEROID REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE (SR AGVHD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anhui Provincial Hospital
RECRUITINGHefei, Anhui, 230036, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.